Crossmark

Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

Crossref DOI link: https://doi.org/10.1007/s10067-022-06145-8

Published Online: 2022-03-30

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bodur, Hatice https://orcid.org/0000-0003-3008-7007
Yurdakul, Fatma Gul https://orcid.org/0000-0001-8630-9233
Ataman, Sebnem https://orcid.org/0000-0003-3570-3825
Cay, Hasan Fatih https://orcid.org/0000-0001-5466-7482
Gurer, Gulcan https://orcid.org/0000-0001-8287-2264
Capkin, Erhan https://orcid.org/0000-0003-2728-5934
Sezer, İlhan https://orcid.org/0000-0003-1324-2108
Duruoz, Mehmet Tuncay https://orcid.org/0000-0003-3584-2788
Melikoglu, Meltem Alkan https://orcid.org/0000-0001-7519-9470
Rezvani, Aylin https://orcid.org/0000-0002-5852-3854
Yagci, Ilker https://orcid.org/0000-0002-5988-7369
Gogus, Feride https://orcid.org/0000-0003-0921-5991
Kamanli, Ayhan https://orcid.org/0000-0001-5299-7250
Akgul, Ozgur https://orcid.org/0000-0003-3012-2968
Cevik, Remzi https://orcid.org/0000-0002-4124-1586
License Information

Text and Data Mining valid from 2022-03-30

Version of Record valid from 2022-03-30
More Information

Article History

Received: 26 November 2021

Revised: 14 March 2022

Accepted: 21 March 2022

First Online: 30 March 2022

Declarations

:

: None.

Document is current

Any future updates will be listed below